Comparison of effects of verapamil and those of nicardipine on myocardial ischemia and reperfusion injury a study in an in situ rabbit model

Japanese Journal of Anesthesiology

Volumn 48, Issue 10, 1999, Pages 1080-1082

  Furuya, Munetaka ^a   Yoshida, Kazu Ichi ^a  

^a KANAGAWA DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ANTAGONIST; KETAMINE; NICARDIPINE; VERAPAMIL; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; ELECTROCARDIOGRAM; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HEART MUSCLE REPERFUSION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; RABBIT; REPERFUSION INJURY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; DISEASE MODELS, ANIMAL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NECROSIS; NICARDIPINE; RABBITS; TIME FACTORS; VERAPAMIL;

EID: 0032750491     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Heupler FA Jr, Proudfit WL Nifedipine therapy for refractory coronary arterial spasm. Am J Cardiol 44 : 798, 1979
2. Antman E, Muller J, Goldberg S, et al Nifedipine therapy for coronary-artery spasm. N Engl J Med 302: 1269, 1980
3. Kloner A, Braunwald E Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 59 : 84 B, 1987
4. Reimer KA, Lowe JE, Jennings RB Effects of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs. Circulation 55: 581, 1977
5. Pearle DL Nifedipine in acute myocardial infarction. Am J Cardiol 54 : 21 E, 1984
6. Muller JE, Morrison J, Stone PH, et al Nifedipine therapy for patients with threatened and acute myocardial infarction: A randomized, double-blind, placebo-controlled comparison. Circulation 69: 740, 1984
7. Thuesen L, Jorgensen JR, Kvistgaard HJ, et al Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: Double-blind randomized trial. Br Med J 286: 1107, 1983
8. Walker MJA, Curtis MJ, Hearse DJ, et al The Lambeth Conventions : Guidelines for the study of arrhythmias in ischaemia, infarction, and reperfusion. Cardiovasc Res 22: 447, 1988
9. Reimer KA, Jennings RB Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Lab Invest 51: 655, 1984
10. Maxwell MP, Hearse DJ, Yellon DM Species variation in the coronary collateral circulation during regional myocardial ischemia : A critical determinant of the rate of evolution and extent of myocardial infarction. Cardiovasc Res 21: 737, 1987
11. Reimer KA, Jennings RB Effects of calcium channel blockers on myocardial preservation during experimental acute myocardial infarction. Am J Cardiol 55: 107 B, 1985
12. Nayler WG, Ferrari R, Williams A Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium. Am J Cardiol 46: 242, 1980
13. Lange R, Ingwall J, Hale SL, et al Preservation of high-energy phosphates by verapamil in reperfused myocardium. Circulation 70: 734, 1984
14. The Danish study group on verapamil in mortality and major events after myocardial infarction. The Danish verapamil injection trial II (DAVIT II). Am J Cardiol 66 779, 1990
15. Alps BJ, Calder C, Wilson A The beneficial effect of nicardipine compared with nifedipine and verapamil in limiting myocardial infarct size in baboons. Arzneimittelforsch 33: 863, 1983
16. Endo T, Nejima J, Fujita S, et al Comparative effects of nicardipine, a new calcium antagonist, on size of myocardial infarction after coronary artery occlusion in dogs. Circulation 74: 420, 1986
17. ++-antagonistic vasodilator, 2,6-dimethyl-4-(3-nitrophenyl)-l, 4-dihydropyridine-3, 5-dicarboxylic acid 3-{ 2-( N-benzyl-N-methylamino)} ethyl ester 5-methyl ester hydrochloride (YC-93) and its mechanisms of the action. J Med Soc Toho, Japan 26: 48, 1979
18. Singh BN, Collett JT, Chew CYC New perspective in the pharmacologie therapy of cardiac arrhythmias. Prog Cardiovasc Dis 22 :243, 1980
19. Cranefield PF, Aronson RS, Wit AL Effect of verapamil on the normal action potential and on a calcium dependent slow response of canine cardiac Purkinje fibers. Circ Res 34 : 204, 1974
20. Wit AL, Cranefield PF Effect of verapamil on the sinoatrial and atrioventricular nodes of the rabbit and the mechanism by which it arrests reentrant atrioventricular tachycardia. Circ Res 35: 413, 1974
21. Surawicz B Role of calcium-blocking agents in treatment of cardiac arrhythmias related to myocardial ischemia. Am Heart J 103: 698, 1982
22. Nayler WG, Perry SE, Elz JS, et al Calcium, sodium, and the calcium paradox. Circ Res 55 : 227, 1984
23. 2+ exchange activity in hearts subjected to hypoxia reoxygenation. Am J Physiol 253 : H 1026, 1987
24. 2+ signalling : Problems and pitfalls. Science 19: 370, 1998